Teva octreotide acetate 10 mg recalled over sterility assurance deficiencies
Teva is recalling two lots of Octreotide Acetate for Injectable Suspension 10 mg after quality system deficiencies were identified during an FDA inspection at the contract manufacturer.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported: this is an FDA Class II recall of an injectable medicine whose sterility cannot be assured, with no injuries stated.
Plain-English summary
Teva Pharmaceuticals USA, Inc is recalling Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, in single-dose 8 mL vial kits, prescription only, manufactured in Greece by Pharmathen International S.A., NDC 0480-9257-08. About 1,897 cartons were distributed nationwide in the United States. The FDA has classified this recall as Class II.
The recall was initiated for lack of assurance of sterility, following quality system deficiencies identified during a routine FDA inspection at the contract manufacturer.
Affected product covers lot 4401619 (expiry 09/30/2026) and lot 4501005 (expiry 03/31/2027).
Patients and pharmacies can identify affected product by the NDC and lot numbers above, and may contact Teva Pharmaceuticals USA, Inc for further information.
The recalled product
- Product
- OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)
- Brand
- OCTREOTIDE ACETATE
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Category
- Drug — Injectable
- Hazard
- sterility-failure
- infection-risk
- injectable
- quality-system-deficiency
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: 4401619
- Exp.: 09/30/2026
- 4501005
- 03/31/2027.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · OCTREOTIDE ACETATE
- SevereOctreotide Acetate Injectable Suspension Recalled Due to Sterility Assurance
FDA (Drugs) · 2026-05-13
- HighTeva octreotide acetate injection recalled over sterility assurance deficiencies
FDA (Drugs) · 2026-04-01
- HighTeva octreotide acetate 20 mg recalled over sterility assurance deficiencies
FDA (Drugs) · 2026-04-01
- CriticalOctreotide Acetate Injection Recalled for Glass Particle Contamination
FDA (Drugs) · 2022-11-16
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22